Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
ArborGen Holdings (ARB) / HY26

Pre-lease FCF fell to NZ$-7.2m as gross borrowings rose 61.9% to NZ$34.0m

A NZ$5.0m working-capital build ahead of the seasonally heavy 2H drove OCF from +NZ$2.1m to -NZ$5.4m and required NZ$13.0m of new borrowings.

Primary Industries / Forestry genetics

ARB revenue trajectory

Revenue context before the current result.

↗
Loading chart...
FY26 was $68.2m, versus $14.2m in HY26.

ARB Operating profit margin

Operating profit margin across covered periods.

↗
Loading chart...
  • FY22 ARB: Outside range high ebitda margin. 21.2%; 3-period range 16.8% to 18.4%. EBITDA margin: 21.2%, above normal range; 3-period mean 17.6%, range 16.8%-18.4%.
  • FY26 ARB: Outside range low ebitda margin. 16.8%; 3-period range 17.7% to 21.2%. EBITDA margin: 16.8%, below normal range; 3-period mean 19.1%, range 17.7%-21.2%.
EBITDA margin: 16.8%, below normal range; 3-period mean 19.1%, range 17.7%-21.2%.

ARB operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
FY26 was $3.7m, versus -$5.4m in HY26.

ARB working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • HY22 ARB: Outside range low operating working-capital movement. $-3.1m; 3-period range $1.5m to $5m. Operating working-capital movement: NZ$-3.1m, below normal range; 3/3 prior periods had builds averaging NZ$2.9m, and none had a working-capital release.
  • FY22 ARB: Outside range high operating working-capital movement. $25.6m; 4-period range $-11.3m to $19.3m. Operating working-capital movement: NZ$25.6m, above normal range; 3/4 prior periods had builds averaging NZ$10.4m, and 1 had releases averaging NZ$-11.3m.
  • FY23 ARB: Unprecedented low operating working-capital movement. $-11.3m; 4-period range $5.6m to $25.6m. Operating working-capital movement: NZ$-11.3m, unprecedented low; 4/4 prior periods had builds averaging NZ$14.2m, and none had a working-capital release.
  • HY26 ARB: Outside range high operating working-capital movement. $5m; 3-period range $-3.1m to $2.3m. Operating working-capital movement: NZ$5.0m, above normal range; 2/3 prior periods had builds averaging NZ$1.9m, and 1 had releases averaging NZ$-3.1m.
Operating working-capital movement: NZ$5.0m, above normal range; 2/3 prior periods had builds averaging NZ$1.9m, and 1 had releases averaging NZ$-3.1m.
Release date
26 November 2025
Published
23 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

HY26 vs HY25

Revenue

$14.2m

+7.6% ↑ vs $13.2m

EBITDA

−$2.1m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net profit after tax

−$0.6m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net cash inflow from operating activities

−$5.4m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Operating profit

−$0.9m

-12.5% ↓ vs −$0.8m

Profit before tax

−$2m

-33.3% ↓ vs −$1.5m

Cash and cash equivalents

$3.6m

-16.3% ↓ vs $4.3m

Total assets

$187.2m

-7.2% ↓ vs $201.8m

What changed

Pre-lease free cash flow swung to NZ$-7.2m in HY26, below the company's historical HY range (Annolyse's baseline mean is NZ$-2.5m across HY22–HY24, with a range of NZ$-4.8m to NZ$-0.8m)

Operating cash flow turned from +NZ$2.1m to -NZ$5.4m, and capex rose 80% to NZ$1.8m (12.7% of revenue). To bridge the gap, gross borrowings rose 61.9% to NZ$34.0m and net debt nearly doubled to NZ$30.4m; cash slipped to NZ$3.6m from NZ$4.3m.

Revenue rose to NZ$14.2m from NZ$13.2m on what the release describes as record HY volumes, predominantly from Brazil (NZ$14.1m, 99.3% of revenue). EBITDA worsened to NZ$-2.1m from NZ$-0.5m and PBT widened to NZ$-2.0m from NZ$-1.5m. Total equity fell to NZ$125.5m from NZ$148.6m.

What matters

Cash conversion broke from its historical HY pattern

Operating working capital rose NZ$5.0m to NZ$48.5m and inventory built NZ$2.1m to NZ$48.8m, consistent with a seasonally weighted 2H selling period, but the resulting pre-lease FCF of NZ$-7.2m sits below the supplied historical HY range. This matters because prior HY working-capital builds have not consumed cash to this extent.

Leverage stepped up sharply. Gross borrowings rose to NZ$34.0m from NZ$21.0m and net debt nearly doubled to NZ$30.4m from NZ$16.7m. The NZ$13.0m of new debt exceeds the NZ$8.3m year-on-year FCF gap, suggesting funding was raised ahead of further 2H working-capital and inventory needs rather than just covering the HY shortfall.

Brazil now carries effectively the entire business. US revenue was NZ$0.1m against Brazil's NZ$14.1m. The release flags that the bulk of US sales are recognised in 2H26, so concentration may normalise across FY26, but the HY26 read-through to underlying earnings is single-geography.

Expectations

The shape context shows HY25 was 20.9% of FY25 revenue, implying NZ$50.0m of 2H25 revenue against the current annualised HY26 run-rate of NZ$28.4m

If a similar shape holds, FY26 revenue should materially exceed the HY annualisation. However, FY25 NPAT was NZ$-21.5m with only NZ$-0.1m booked in HY25, meaning effectively the entire FY25 loss landed in 2H.

No FY26 guidance, quantified 2H expectation, or stated target was provided. The seasonal shape means an HY26 loss does not by itself signal FY26 deterioration, but it also offers no early read on whether 2H26 will repeat the heavy 2H25 NPAT outcome.

Quality of result

The HY26 result is a working-capital and capex-driven cash outflow rather than an earnings reset

PBT margin at -14.1% is at the upper edge of the supplied historical HY range (mean -17.5%), and EBITDA of NZ$-2.1m, while weaker than HY25, is broadly consistent with the company's HY loss pattern given second-half-weighted revenue. The effective tax rate of 70.0% is above the historical baseline (mean -16.3%) and reflects tax accounting on a small pre-tax loss; PBT is therefore the cleaner read on underlying operating performance.

Where the result looks lower quality is the cash side. The NZ$7.5m OCF swing, the 80% step-up in capex, and a pre-lease FCF position below the historical HY range together pushed equity down NZ$23.1m and total assets to NZ$187.2m, below the company's historical HY asset baseline of NZ$198.6m. These movements need to reverse meaningfully in 2H26 for FY26 cash and balance-sheet metrics to look comparable to recent years.

Unresolved

Open questions

What specifically drove the NZ$7.5m OCF swing beyond the disclosed inventory and receivables movements?
Why did gross borrowings rise NZ$13.0m when the year-on-year FCF gap was NZ$8.3m, and what is the remaining undrawn facility?
How does management expect the NZ$48.8m inventory balance to convert through 2H26 seedling sales?
Will US revenue recognition in 2H26 materially reduce the 99.3% Brazil concentration, and what level is management targeting?
Does management expect FY26 NPAT to repeat the heavy 2H25 loss pattern, or is the 2H NPAT trajectory expected to differ?

This briefing cannot assess management's specific 2H26 revenue, margin, or working-capital expectations because no quantitative forward guidance or target was disclosed in the release.

Chat

Ask about ARB HY26

Ask follow-up questions about ArborGen Holdings's HY26 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about ARB HY26

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about ArborGen Holdings's HY26 result.

What specifically drove the NZ$7.5m OCF swing beyond the disclosed inventory and receivables movements?Why does "Cash conversion broke from its historical HY pattern" matter?How strong was the cash and earnings quality in HY26?What should I watch next for ARB after HY26?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

ArborGen Holdings Limited - Interim Report for the six months ended 30 September 2025

HY26 / financial report↗

ArborGen Holdings Limited - Interim Results to 30 September 2025

HY26 / results announcement↗

ArborGen Holdings Limited - Interim Results to 30 September 2025

HY26 / results release↗

Prior comparable period

Amended 1H24 Interim Report

HY25 / financial report↗

Full-year context

ArborGen Holdings - Audited Financial Statements for year ended 31 March 2025

FY25 / financial report↗

Related insights

Cross-company views selected from the metrics in this briefing.

Cash conversion quality

This result converted 257.1% of EBITDA to operating cash flow, +677.1pp versus the prior comparable period.

→

Earnings quality and statutory distortions

This result includes a statutory earnings-quality distortion flag.

→

Revenue growth context

Revenue growth was 7.6% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when ARB publishes next

Get the next ArborGen Holdings briefing and related NZX reporting-season updates by email.